[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[2]
|
Ye, D. and Zhu, Y. (2015) Epidemiology of Prostate Cancer in China: An Overview and clinical Implication. Chinese Journal of Surgery, 53, 249-252.
|
[3]
|
Walsh, A.L., Considine, S.W., Thomas, A.Z., Lynch, T.H. and Manecksha, R.P. (2014) Digital Rectal Examination in Primary Care Is Important for Early Detection of Prostate Cancer: A Retrospective Cohort Analysis Study. British Journal of General Practice, 64, e783-e787. https://doi.org/10.3399/bjgp14X682861
|
[4]
|
Naji, L., Randhawa, H., Sohani, Z., Dennis, B., Lautenbach, D., Kavanagh, O., Bawor, M., Banfield, L. and Profetto, J. (2018) Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis. Annals of Family Medicine, 16, 149-154. https://doi.org/10.1370/afm.2205
|
[5]
|
Caliskan, S. (2017) Diagnostic Efficacy of Free Prostate-Specific Antigen/Total Prostate-Specific Antigen Ratio for the Diagnosis of Prostate Cancer in Low Concentration (≤4 ng/ml) and Intermediate Levels of Total Prostate-Specific Antigen (4.01-10.0 ng/ml). Journal of Cancer Research and Therapeutics, 13, 279-283.
https://doi.org/10.4103/0973-1482.183177
|
[6]
|
Catalona, W.J., Smith, D.S., Wolfert, R.L., Wang, T.J., Rittenhouse, H.G., Ratliff, T. and Nadler, R.B. (1995) Evaluation of Percentage of Free Serum Prostate-Specific Antigen to Improve Specificity of Prostate Cancer Screening. JAMA, 274, 1214-1220. https://doi.org/10.1001/jama.1995.03530150038031
|
[7]
|
Teoh, J.Y., Yuen, S.K., Tsu, J.H., Wong, C.K., Ho, B.S., Ng, A.T., Ma, W.K., Ho, K.L. and Yiu, M.K. (2017) The Performance Characteristics of Prostate-Specific Antigen and Prostate-Specific Antigen Density in Chinese Men. Asian Journal of Andrology, 19, 113-116.
|
[8]
|
Aganovic, D., Prcic, A., Kulovac, B. and Hadziosmanovic, O. (2012) Influence of the Prostate Volume, Prostate Specific Antigen Density and Number of Biopsy Samples on Prostate Cancer Detection. Medical Archives, 66, 41-44.
https://doi.org/10.5455/medarh.2012.66.41-44
|
[9]
|
Loeb, S., Roehl, K.A., Catalona, W.J. and Nadler, R.B. (2007) Prostate Specific Antigen Velocity Threshold for Predicting Prostate Cancer in Young Men. The Journal of Urology, 177, 899-902.
https://doi.org/10.1016/j.juro.2006.10.028
|
[10]
|
Totaro, A., Di Gianfrancesco, L., Pinto, F., Racioppi, M., Palermo, G., Campetella, M., Santoro, A.A., Arbia, G. and Sacco, E. (2021) Rate of Clinically Significant Prostate Cancer on Repeat Saturation Biopsy after a Diagnosis of Atypical Small Acinar Proliferation. Urologia, 88, 194-199. https://doi.org/10.1177/0391560321993595
|
[11]
|
Pradere, B., Veeratterapillay, R., Dimitropoulos, K., Yuan, Y., Omar, M.I., MacLennan, S., Cai, T., Bruyère, F., Bartoletti, R., Köves, B., Wagenlehner, F., Bonkat, G. and Pilatz, A. (2021) Nonantibiotic Strategies for the Prevention of Infectious Complications Following Prostate Biopsy: A Systematic Review and Meta-Analysis. The Journal of Urology, 205, 653-663. https://doi.org/10.1097/JU.0000000000001399
|
[12]
|
Hossack, T., Patel, M.I., Huo, A., Brenner, P., Yuen, C., Spernat, D., Mathews, J., Haynes, A.M., Sutherland, R., del Prado, W. and Stricker, P. (2012) Location and Pathological Characteristics of Cancers in Radical Prostatectomy Specimens Identified by Transperineal Biopsy Compared to Transrectal Biopsy. The Journal of Urology, 188, 781-785.
https://doi.org/10.1016/j.juro.2012.05.006
|
[13]
|
Crawford, E.D., Rove, K.O., Barqawi, A.B., Maroni, P.D., Werahera, P.N., Baer, C.A., Koul, H.K., Rove, C.A., Lucia, M.S. and La Rosa, F.G. (2013) Clinical-Pathologic Correlation between Transperineal Mapping Biopsies of the Prostate and Three-Dimensional Reconstruction of Prostatectomy Specimens. Prostate, 73, 778-87.
https://doi.org/10.1002/pros.22622
|
[14]
|
van der Leest, M., Cornel, E., Israël, B., Hendriks, R., Padhani, A.R., Hoogenboom, M., Zamecnik, P., Bakker, D., Setiasti, A.Y., Veltman, J., van den Hout, H., van der Lelij, H., van Oort, I., Klaver, S., Debruyne, F., Sedelaar, M., Hannink, G., Rovers, M., Hulsbergen-van de Kaa, C. and Barentsz, J.O. (2019) Head-to-Head Comparison of Transrectal Ultrasound-Guided Prostate Biopsy versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-Guided Biopsy in Biopsy-Naïve Men with Elevated Prostate-Specific Antigen: A Large Prospective Multicenter Clinical Study. European Urology, 75, 570-578. https://doi.org/10.1016/j.eururo.2018.11.023
|
[15]
|
Baboudjian, M., Bandelier, Q., Gondran-Tellier, B., Abdallah, R., Michel, F., Sichez, P.C., Di-Crocco, E., Akiki, A., Gaillet, S., Delaporte, V. andre, M., Daniel, L., Karsenty, G., Lechevallier, E. and Boissier, R. (2020) MRI-Targeted Biopsy for Detecting Prostate Cancer: Have the Guidelines Changed Our Practices and Our Prostate Cancer Detection Rate? International Urology and Nephrology, 52, 611-618. https://doi.org/10.1007/s11255-019-02353-5
|
[16]
|
Oberlin, D.T., Casalino, D.D., Miller, F.H., Matulewicz, R.S., Perry, K.T., Nadler, R.B., Kundu, S., Catalona, W.J. and Meeks, J.J. (2016) Diagnostic Value of Guided Biopsies: Fusion and Cognitive-Registration Magnetic Resonance Imaging versus Conventional Ultrasound Biopsy of the Prostate. Urology, 92, 75-79.
https://doi.org/10.1016/j.urology.2016.02.041
|
[17]
|
Hanna, N., Wszolek, M.F., Mojtahed, A., Nicaise, E., Wu, B., Gelpi-Hammerschmidt, F.J., Salari, K., Dahl, D.M., Blute, M.L., Harisinghani, M. and Feldman, A.S. (2019) Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Biopsy Improves but Does Not Replace Standard Template Biopsy for the Detection of Prostate Cancer. The Journal of Urology, 202, 944-951. https://doi.org/10.1097/JU.0000000000000359
|
[18]
|
BarbasBernardos, G., Herranz Amo, F., de Miguel Campos, E., Luis Cardo, A., Herranz Arriero, A., Cancho Gil, M.J., Caño Velasco, J., JaraRascón, J., Mayor de Castro, J. and Hernández Fernández, C. (2019) Comparison of Classical Transrectal Prostate Biopsy versus Cognitive Registration in Rebiopsy. Actas Urológicas Españolas (Engl Ed). 43, 228-233. https://doi.org/10.1016/j.acuroe.2018.06.010
|
[19]
|
Soga, N., Yatabe, Y., Ogura, Y. and Hayashi, N. (2015) Additional Midline Biopsies of the Peripheral Zone Associated with the First Endorectal Standard Sextant Pattern Improves the Accuracy of Prostate Cancer Detection in Japanese Patients. Current Urology, 8, 74-78. https://doi.org/10.1159/000365693
|
[20]
|
Scattoni, V., Roscigno, M., Raber, M., Dehò, F., Maga, T., Zanoni, M., Riva, M., Sangalli, M., Nava, L., Mazzoccoli, B., Freschi, M., Guazzoni, G., Rigatti, P. and Montorsi, F. (2008) Initial Extended Transrectal Prostate Biopsy—Are More Prostate Cancers Detected with 18 Cores than with 12 Cores? The Journal of Urology, 179, 1327-1331.
https://doi.org/10.1016/j.juro.2007.11.052
|
[21]
|
Ghafoori, M., Velayati, M., AliyariGhasabeh, M., Shakiba, M. and Alavi, M. (2015) Prostate Biopsy Using Transrectal Ultrasonography; The Optimal Number of Cores Regarding Cancer Detection Rate and Complications. Iranian Journal of Radiology, 12, e13257. https://doi.org/10.5812/iranjradiol.13257
|
[22]
|
Ploussard, G., Nicolaiew, N., Marchand, C., Terry, S., Vacherot, F., Vordos, D., Allory, Y., Abbou, C.C., Salomon, L. and de la Taille, A. (2014) Prospective Evaluation of an Extended 21-Core Biopsy Scheme as Initial Prostate Cancer Diagnostic Strategy. European Urology, 65, 154-161. https://doi.org/10.1016/j.eururo.2012.05.049
|
[23]
|
Guo, G., Xu, Y. and Zhang, X. (2017) TRUS-Guided Transperineal Prostate 12+X Core Biopsy with Template for the Diagnosis of Prostate Cancer. Oncology Letters, 13, 4863-4867. https://doi.org/10.3892/ol.2017.6051
|
[24]
|
Borghesi, M., Ahmed, H., Nam, R., Schaeffer, E., Schiavina, R., Taneja, S., Weidner, W. and Loeb, S. (2017) Complications after Systematic, Random, and Image-Guided Prostate Biopsy. European Urology, 71, 353-365.
https://doi.org/10.1016/j.eururo.2016.08.004
|
[25]
|
Raaijmakers, R., Kirkels, W.J., Roobol, M.J., Wildhagen, M.F. and Schrder, F.H. (2002) Complication Rates and Risk Factors of 5802 Transrectal Ultrasound-Guided Sextant Biopsies of the Prostate within a Population-Based Screening Program. Urology, 60, 826-830. https://doi.org/10.1016/S0090-4295(02)01958-1
|
[26]
|
Nam, R.K., Saskin, R., Lee, Y., Liu, Y., Law, C., Klotz, L.H., Loblaw, D.A., Trachtenberg, J., Stanimirovic, A., Simor, A.E., Seth, A., Urbach, D.R. and Narod, S.A. (2013) Increasing Hospital Admission Rates for Urological Complications after Transrectal Ultrasound Guided Prostate Biopsy. The Journal of Urology, 189, S12-S17.
https://doi.org/10.1016/j.juro.2012.11.015
|